Kuban DA - Search Results

1

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.

Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL. Horwitz EM, et al. Among authors: kuban da. J Urol. 2005 Mar;173(3):797-802. doi: 10.1097/01.ju.0000152556.53602.64. J Urol. 2005. PMID: 15711272

2

Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate.

Kuban DA, Delbridge T, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. J Urol. 1989 Mar;141(3):572-4. doi: 10.1016/s0022-5347(17)40897-4. J Urol. 1989. PMID: 2465419

3

Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Urology. 1987 Nov;30(5):420-6. doi: 10.1016/0090-4295(87)90372-4. Urology. 1987. PMID: 3118547

4

Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.

Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Kim JA, et al. Among authors: kuban da. Radiology. 1995 Feb;194(2):545-9. doi: 10.1148/radiology.194.2.7529936. Radiology. 1995. PMID: 7529936

5

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):307-16. doi: 10.1016/0360-3016(95)00137-N. Int J Radiat Oncol Biol Phys. 1995. PMID: 7538499

6

Prognostic significance of post-irradiation prostate biopsies.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Oncology (Williston Park). 1993 Feb;7(2):29-38; discussion 40, 43-4, 47. Oncology (Williston Park). 1993. PMID: 7679918 Review.

7

Treatment of clinical local failure after radiation therapy for prostate carcinoma.

Schellhammer PF, Kuban DA, el-Mahdi AM. Schellhammer PF, et al. Among authors: kuban da. J Urol. 1993 Dec;150(6):1851-5. doi: 10.1016/s0022-5347(17)35913-x. J Urol. 1993. PMID: 8230518

8

PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: do we know how to use it?

Kuban DA, El-Mahdi AM, Schellhammer PF. Kuban DA, et al. Semin Radiat Oncol. 1998 Apr;8(2):72-80. doi: 10.1016/s1053-4296(98)80002-7. Semin Radiat Oncol. 1998. PMID: 9516587 Review.

9

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Shipley WU, et al. Among authors: kuban da. JAMA. 1999 May 5;281(17):1598-604. doi: 10.1001/jama.281.17.1598. JAMA. 1999. PMID: 10235152

10

The durability of external beam radiation therapy for prostate cancer: can it be identified?

Davis JW, Kolm P, Wright GL Jr, Kuban D, El-Mahdi A, Schellhammer PF. Davis JW, et al. J Urol. 1999 Sep;162(3 Pt 1):758-61. doi: 10.1097/00005392-199909010-00036. J Urol. 1999. PMID: 10458360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters